Top Papers from the Last Year You Need to Know About

Tracy Minichiello. University of California, San Francisco

New Antithrombotic Agents

Deborah Siegal. McMaster University

Guidance Updates from ASH and ACC

Daniel Witt. University of Utah College of Pharmacy

Anticoagulants for Secondary Prevention of CAD/PAD

John Eikelboom. McMaster University

What is PAD and How Should I Treat It?

Heather Gornik. Cleveland Clinic

Combined Antithrombotic Therapy: Is There a Role for it in 2019?

Renato Lopes. Duke University

Description of Anticoagulation Use, Risk Factors and Patient Population in a Pharmacist Managed Anticoagulation Clinic in Rural, Western Kenya.

John Kanyi¹, Sara Fletcher², Sarah Kipkulei³, Shirley Boit¹, Samuel Nyanje⁴, Everton Wanakacha⁴, Elvis Aswani⁴, Emily Deremiah², Madeleine Ochs², Emily Buatois², Imran Manji¹, Rakhi Karwa², Sonak D Pastakia². ¹Moi Teaching a Referral Hospital, Eldoret, Kenya. ²Purdue University College of Pharmacy, Indiana, IN, USA. ³Moi Teaching a Referral Hospital College of Health Sciences, Eldoret, Kenya. ⁴Academic Model Providing Access To Healthcare (AMPATH), Eldoret, Kenya

Improving Access, Quality and Cost with Centralized Anticoagulation Services Hub: Service Establishment and Workflow

Megan Grischeau, Melissa Fontana, Andrea Mendyk, Dana Frank, Sandra Hedin. VHA - VISN 12, Hines, IL, USA

Integration of Direct Oral Anticoagulation Care into a Traditional Warfarin Clinic: A Single Academic Center Experience and Pilot Study

Pamela Burgwinkle, MS, NP-C, ¹, Patricia Shreve, DNP, APRN¹, David McManus, MD^{1, 2}, Brian Smith, PharmD¹, Sarah Nadeau, CPHT¹, Jaclyn Piche, RN, BSN¹. ¹Umassmemorial Hospital, Worcester, MA, USA. ²University of Massachusetts Medical School, Worcester, MA, USA

Impact of a Direct Oral Anticoagulant Population Management Tool on Anticoagulation Therapy Monitoring in Clinical Practice

Daniela Valencia¹, Patrick Spoutz², Jaclyn Stoppi¹, Jeffery L Kibert³, Arthur Allen⁴, David Parra^{5, 6}, Augustus Hough ¹. ¹West Palm Beach VA Medical Center, West Palm Beach, FL, USA. ²Kansas City VA Medical Center, Kansas, MO, USA. ³William Jennings Bryan Dorn VA Medical Center, Columbia, SC, USA. ⁴Salt Lake City VA Medical Center, Salt Lake, UT, USA. ⁵Veterans Integrated Service Network 8, Pharmacy Benefits Management, Bay Pines, FL, USA. ⁶Department of Experimental and Clinical Pharmacology, University of Minnesota College of Pharmacy, Minneapolis, Mineapolis, MN, USA

Evaluation of rivaroxaban prescription adherence rates compared to warfarin for venous thomboembolism at a large teaching hospital

Desire' L. Outler¹, Sweta M. Patel^{1, 2}, Jennifer B. Elliott^{1, 2}, Michael D. Knauss², Mikhail Y. Akbashev³. ¹Mercer University College of Pharmacy, Atlanta, GA, USA. ²Grady Health System, Atlanta, GA, USA. ³Emory University School of Medicine, Atlanta, GA, USA

Telehealth: A New Innovative Approach in Anticoagulation Management

Maria Vega, ANP-BC ¹, Libiny John, FNP-BC², Susan Sciortino, FNP-BC², Elise Arambages, FNP-BC², Danielle Auletta, MPA¹, Ilias Nickolakopoulos, MD³, Alex Spyropoulos, MD^{1, 2, 3, 4}. ¹Northwell Health at Lenox Hill Hospital, NY, NY, USA. ²Northwell Health at Staten Island University, Staten Island, NY, USA. ³Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA. ⁴Center for Health Innovations and Outcomes Research - The Feinstein Institute for Medical Research, Manhasset, NY, USA

Monitoring Direct Oral Anticoagulants Using a Dashboard Model Versus Standard Care in a Federal Health Care Setting

Suzanne T. Chau. Captain James A. Lovell Federal Health Care Center, North Chicago, IL, USA

Evaluation of appropriate prescribing and management of direct oral anticoagulants (DOACs) in internal medicine and cardiovascular clinics and the feasibility of expanding current pharmacist-provided outpatient anticoagulation services.

Ashley Yarabinec¹, Margaret Castelli¹, Brittany Rosenfeld¹, Nancy Kablack¹, Cynthia Wessel¹, Nicole Handlow¹, Lindsey Jachim¹, Swana Thomas¹, Nicole Modany¹, Andrew Bever², Caroline Dillon², Michael Hagerty¹, Paula Horn¹. ¹Allegheny General Hospital Department of Pharmacy Services, Pittsburgh, PA, USA. ²Duquesne University School of Pharmacy, Pittsburgh, PA, USA

Analysis of Quality Measures Before and After Switching Care Models in MAQI2 Anticoagulation Clinics.

Joseph Maniaci¹, Constantina Alexandris-Souphis¹, Helen Gikas², Mona Ali³, Scott Kaatz², Brian Haymart¹, Nannette Gearhart³, Mary DeYoung⁴, Stacy Ellsworth², Jim Froehlich¹, Geoff Barnes¹, Eva Kline-Rogers¹, Noelle Ryan². ¹University of Michigan, Ann Arbor, MI, USA. ²Henry Ford Health System, Detroit, MI, USA. ³Beaumont Health System, Royal Oak, MI, USA. ⁴Spectrum Health, Grand Rapids, MI, USA

Evaluation of a direct oral anticoagulation (DOAC) stewardship program: analysis of a drug consult review process and population based management tool

Carli Smith, Haley Henry, Bishoy Ragheb, Ashley Thomas, Jennifer Baker. VA Tennessee Valley Healthcare System, Murfreesboro, TN, USA

Measuring the impact of a pharmacist-managed direct oral anticoagulant service

Katie Xu, Aaron Dush, H. Paige Erdeljac, Stephanie Yager, Tzu-Fei Wang. The Arthur G James Cancer Hospital and Richard J Solove Research Institute at The Ohio State University, Columbus, OH, USA

Pharmacists as Front Line Clinicians in a New Multidisciplinary Thrombosis Service

Stephanie Young^{1, 2}, Rachel Ward¹, Rufaro Chitsike^{2, 1}. ¹Memorial University, St. John's, NL, Canada. ²Eastern Health Regional Health Authority, St. John's, NL, Canada

Patient satisfaction with warfarin therapy on extended international normalized ratio follow-up intervals

Andrea Porter^{1, 2}, Rebecca Schoen³, Michael Nagy⁴, Amanda Margolis^{1, 2}. ¹University of Wisconsin-Madison School of Pharmacy, Madison, WI, USA. ²William S. Middleton Memorial Veterans Hospital, Madison, WI, USA. ³Texas Tech University Health Sciences Center, Dallas, TX, USA. ⁴Medical College of Wisconsin Pharmacy School, Milwaukee, WI, USA

Evaluation of anticoagulation in patients with atrial fibrillation admitted with acute ischemic stroke

Brian Carlone, Elizabeth LaRose, Joleen Bierlein, Stephen Rolfe, Wesley Zemrak. Maine Medical Center, Portland, ME, USA

The Impact of CYP2C19 Genetic Mutation and Non-Genetic Factors on the Incidence of Major Adverse Cardiovascular Events in patients treated with Clopidogrel in Qatar

Zainab Ali¹, Loulia Bader¹, Dania Al-Masri¹, Mariam Ali², Salah Arafa², Abdulrahman Arabi², Shaban Mohammed², Nasser Rizk³, Fatima Mraiche¹, hazem Elewa^{1, 2}. ¹College of Pharmacy, Doha, Qatar. ²Hamad Medical Corporation, Doha, Qatar. ³College of Health Science, Doha, Qatar

When Less is More: An Anticoagulation Service Initiative to Target Combination Antithrombotic Therapy

Christina Meadows¹, Arthur Allen². ¹VA Salt Lake City Health Care System, Salt Lake City, UT, USA. ²VA Salt Lake City Health Care System, Salt Lake City, UT, USA

Real World Safety Analysis of Combined Single Antiplatelet and Anticoagulant Therapy in Patients with Atrial Fibrillation.

Stephanie Tran¹, Patrick Klem^{1, 2}, Kerry Schwarz², Toby Trujillo^{1, 2}. ¹University of Colorado, Aurora, CO, USA. ²University of Colorado Hospital, Aurora, CO, USA

Direct Oral Anticoagulation plus Antiplatelet Therapy: Prescribing Rates and Bleeding Outcomes

Tyler T. Tinkham¹, Sara R. Vazquez^{1, 2}, Aubrey E. Jones^{1, 2}, Daniel M. Witt^{1, 2}. ¹University of Utah, Salt Lake City, UT, USA. ²Thrombosis Service, University of Utah Health, Salt Lake City, UT, USA

Direct Oral Anticoagulant Versus Warfarin for Deep Vein Thrombosis/ Pulmonary Embolism: A Comparison of Cost, Reimbursement, and Length of Stay

Zachary Robinson ¹, Stephanie Cailor², Joseph Metz¹. ¹Premier Health, Dayton, OH, USA. ²Dayton V. A, Dayton, OH, USA

Comparison of Two Intravenous Unfractionated Heparin Dosing Strategies: aPTT and Anti-Xa Monitoring

Nicole Free, Becky Szymanski, Tina Hipp, Nigel Rozario. Carolinas HealthCare System NorthEast, Concord, NC, USA

Evaluation of safety and efficacy of direct oral anticoagulants in the treatment of heparin-induced thrombocytopenia

Alina Kukin, Amanda Liszewski, Surabhi Palkimas. University of Virginia Health System, Charlottesville, VA, USA

Challenges of Converting to Anti-Xa Monitoring of IV Unfractionated Heparin in an Oral Factor Xa Inhibitor Era

Van Q. Pham, Linh L. Chan, Walter L. Crumpler, Anita Wang, Alan K. Jacobson. VA Loma Linda HCS, Loma Linda, CA, USA

Appropriateness of Blood Concentrations of Direct Oral Anticoagulants in Patients at High Risk ofUnder or Over Exposure

Olga Sherman, Diana Otero, Lawrence Baruch. James J Peters VAMC, Bronx, NY, USA

Description of Anti-Xa Monitoring Practices During Low Molecular Weight Heparin Use

Albert Lin, Sara Vazquez, Aubrey Jones, Daniel Witt. University of Utah College of Pharmacy, Salt Lake City, UT, USA

Anticoagulant Lab Panel for Emergent Reversal of Apixaban and Rivaroxaban

Kimberly Hodulik, Adam Root, Maria Notini, Charles Stewart, Thomas Ortel. Duke Hospital, Durham, NC, USA

Direct Oral Anticoagulant Drug Level Testing: Experience from an Outpatient Anticoagulation Clinic

Krista Luck, Kristin Duffey, Sara Iacono. Mission Hospital, Asheville, NC, USA

Anti-Factor Xa Ordering Practices for Apixaban and Rivaroxaban within an Academic Medical Center

Anne Rose, David Ciske, Erin Robinson, Eliot Williams. UW Health, Madison, WI, USA

Higher Oral Anticoagulation Knowledge (OAK)Score at Baseline Associated with Better Time in Therapeutic Range(TTR) in Patients Taking Warfarin

Constantina Alexandris-Souphis¹, Delaney Feldeisen¹, Brian Haymart¹, Xiaokui GU¹, Stephanie Watts², Renee Kozlowski², Jay Kozlowski², James Froehlich¹, Geoff Barnes¹, Eva Kline-Rogers¹. ¹Michigan Medicine/MCORRP, Ann Arbor, MI, USA. ²Huron Valley Hospital/Cardiology and Vascular Associates PC, Commerce, MI, USA

Preferences for after-visit summaries: an analysis of how patients prefer to receive their after-visit summary from the anticoagulation management clinic at Cone Health Internal Medicine Center

Abu S. Azad¹, Jennifer J. Kim^{1, 2}, James B. Groce^{2, 3}. ¹UNC Eshelman School of Pharmacy, Chapel Hill, NC, USA. ²Cone Health, Greensboro, NC, USA. ³Campbell University College of Pharmacy and Health Sciences, Buies Creek, NC, USA

Assessing Patient Preferences for Switching to Direct Oral Anticoagulants

Jack N. Wright, Sara R. Vazquez, Aubrey E. Jones, Kibum Kim, Daniel M. Witt. University of Utah College of Pharmacy, Salt Lake City, UT, USA

Reduction of ED Visits for Epistaxis in Patients Taking Coumadin after a Patient Education Program

Constantina Alexandris-Souphis, Brian Haymart, Delaney Feldeisen, Xiaowen Kong, Rebecca Harvey, Melissa Pynnonen, James Froehlich, Eva Kline-Rogers, Geoffrey Barnes. Michigan Medicine/MCORRP, Ann Arbor, MI, USA

Transitioning patients to Warfarin Self-Management using a Computer-based Home Monitoring Model with Point of Care Testing

Samer Makhaly, Lissa Ajjamada, Tanya Sakamene, Kim Ma, Susan Solymoss. McGill University Health Center, Montreal, QC, Canada

Point-of-care vs venipuncture international normalized ratio testing in adult patients with ventricular assist devices at a large tertiary academic medical center

Amy Levesque¹, Katelyn Sylvester¹, Jean Connors². ¹Brigham and Women's Hospital, Department of Pharmacy Services, Boston, MA, USA. ²Brigham and Women's Hospital, Division of Hematology, Boston, MA, USA

Interruption of Warfarin for Low-Risk Procedures

Austin Foote¹, Brian Haymart¹, Xiaowen Kong¹, Mona Ali², Scott Kaatz³, Eva Kline-Rogers¹, Jay Kozlowski⁴, Tina Alexandris-Souphis¹, James B. Froehlich¹, Geoffrey D. Barnes¹. ¹University of Michigan, Ann Arbor, MI, USA. ²Beaumont Hospital, Royal Oak, MI, USA. ³Henry Ford Hospital, Detroit, MI, USA. ⁴Huron Valley-Sinai Hospital, Commerce, MI, USA

Post-procedure warfarin resumption dosing strategies and related outcomes in patients bridged with enoxaparin

Maria Goldman, Stacy Ogle. Carroll Hospital, Wesminster, MD, USA

Warfarin managment for arterial thromboembolism originating from extracardiac source at a veteran affairs medical center

Jiji Thomas, Tiffany Boelke, Rachel Barr. Richard L Roudebush Veteran Affairs Medical Center, Indianapolis, IN, USA

Implementation of an anticoagulation quality metrics reporting program using the electronic health record across a large academic medical system

Lisa Moherman¹, Valerie Moyer¹, Joshua Koenig¹, Briana Kocher¹, Stephanie Iyer², Daniel O'Neil¹. ¹WVU Medicine, Morgantown, WV, USA. ²UNC Health Care, Chapel Hill, NC, USA

Need Assessment of Establishing Pharmacist Managed Anticoagulation Clinic at Tikur Anbessa Specialized Hospital: Quality Improvement Study

Tamrat Assefa¹, Asmamaw Yenesew¹, Girma Eshetu¹, Nuredin Shiferaw¹, Minyahil Alebachew¹. ¹Addis Ababa University, Addis Ababa, Ethiopia. ²Addis Ababa University, Addis Ababa, Ethiopia. ³Addis Ababa University, Addis Ababa, Ethiopia. ⁴Addis Ababa University, Addis Ababa, Ethiopia. ⁵Addis Ababa University, Addis Ababa, Ethiopia

Impact of Implementation of an Antithrombin Replacement Guideline in a Pediatric Institution

Ying Lee¹, Anh Hoang¹, Caitlin Le¹, Courtney Long¹, Ayesha Zia². ¹Children's Health , Dallas, TX, USA. ²UT Southwestern Medical Center, Dallas, TX, USA

Optimizing anticoagulation for patients with low time-in-therapeutic range

Naomi Yates, Alex Kilgore. Kaiser Permanente, Atlanta, GA, USA

Pharmacist-Led Intervention to Address Patients with Atrial Fibrillation Not Receiving Anticoagulation

Tachanda M. Mensah, Naomi Y. Yates. Kaiser Foundation Health Plan of Georgia, Inc, Atlanta, GA, USA

Retrospective evaluation of the use of proton pump inhibitors in patients on concomitant anticoagulant and antiplatelet therapy

Tanvi Patil PharmD, BCPS, Kimberly Murphy, PharmD, Laura Woodard, PharmD, Morgan Lebrecht, PharmD. Veterans Health Administration, Salem, VA, USA

Assessing knowledge and practice of hospital and community pharmacists towards Direct Oral Anticoagulants (DOACs) in Qatar

ahmed El-Bardissy¹, Shaban Mohammed¹, Ahmed Shible¹, Rizwan Imanullah¹, Abdul Moqeeth Mohammed¹, hazem Elewa^{1, 2}. ¹Hamad Medical Corporation, Doha, Qatar. ²Qatar University, Doha, Qatar

Aspirin and Warfarin: A Combination for Everyone?

Katherine Huang¹, Vinay Shah¹, Syed Ahsan¹, Scott Kaatz¹, Greg Krol¹, Stacy Ellsworth¹, Noelle Ryan¹, Jeremy Gentile¹, Brandon Wilkinson². ¹Henry Ford Health System, Detroit, MI, USA. ²Wayne State University School of Medicine, Detroit, MI, USA

US Emergency Department Visits for Oral Anticoagulant-related Bleeding, 2017

Andrew I. Geller¹, Daniel S. Budnitz¹, Kathleen O. Rose², Nina J. Weidle³, Sandra K. Goring², Ruth N. Moro², Maribeth C. Lovegrove¹, Nadine Shehab¹. ¹Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA. ²Northrop Grumman Corporation (contractor to the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention), Atlanta, GA, USA. ³Eagle Contracting LLC (contractor to the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention), Atlanta, GA, USA

Assessing Appropriateness of Warfarin Care Plans Upon Referral to an Outpatient Anticoagulation Service

Elizabeth Renner, Erin Mouland, Samira Saad, Nghi Ha. University of Michigan, Ann Arbor, MI, USA

Reasons for Discontinuation of Direct Oral Anticoagulant Therapy in Patients with Non-Valvular Atrial Fibrillation

Elizabeth Renner¹, Erin Mouland¹, Samira Saad¹, Nghi Ha¹, Pauline Kim². ¹University of Michigan, Ann Arbor, MI, USA. ²Indiana University Health, Indianapolis, IN, USA

Concomitant use of non-steroidal anti-inflammatory drugs and direct oral anticoagulants

Quratulain Zulfiqar, Carolyn Combs, Kim Hall. Bay Pines Veterans Affairs Healthcare System, Bay Pines, FL, USA

Providers’ perceptions of warfarin dosing nomograms

Trevor Gardner, Sara R. Vazquez, Aubrey E. Jones, Kibum Kim, Daniel M. Witt. University of Utah, College of Pharmacy, Salt Lake City, UT, USA

Do Hospitalized Patients Receive AppropriateVenous ThromboembolismProphylaxis?

Ankita Patel, Sarah Stuart, Valerie Allusson , Richard Adamczyk , Roveena Goveas, Mikita Patel, Sonia Ahmed, Ummi Khan. Hackensack Meridian Mountainsidehosp. com, Montclair, NJ, USA

Implementation of Anticoagulation Centers of Excellence Standards To Improve Time in Therapeutic Range

Ashley M. Thomas¹, Nilam Naik², Bishoy Ragheb¹. ¹VA Tennessee Valley Healthcare System, Murfreesboro, TN, USA. ²VA Tennessee Valley Healthcare System, Nashville, TN, USA

Evaluation of apixaban and rivaroxaban utilization for acute venous thromboembolism at a Western Michigan community teaching hospital

Kristen Johnson, Josh Jacoby, Dan Boldt. Mercy Health Saint Mary's, Grand Rapids, MI, USA

Adding Low Dose Vitamin K Supplements to Warfarin Regimen to Improve Poor Individual Time-In-Range of International Normalized Ratio's

Shelly A. Keune, Carol A. Abullarade, Bruce E. Burnett. Park Nicollet, St. Louis Park, MN, USA

Prescribing pattern of oral anticoagulants in patients with obesity

Kristina Falk, Meghan McComb, Nancy L Shapiro, Ellen Uppuluri. University of Illinois, Chicago, IL, USA

Disproportionate Anticoagulation and Opioid Keyword Frequencies in Hospital Regulations

Youssef Bessada¹, Darren M. Triller², Katherine P. Cabral¹, Scott Kaatz³. ¹Albany College of Pharmacy and Health Sciences, Albany, NY, USA. ²WellScriptED Consulting Inc, Delmar, NY, USA. ³Wayne State University, Detroit, MI, USA

Andexanet alfa for Treatment of Factor Xa inhibitor-related Acute Major Bleeding

Todd Fralich¹, Truman John Milling Jr. ², Stuart J Connolly³, John Eikelboom³, C Michael Gibson⁴, Pamela B Conley¹, Peter Verhamme⁵, Jeannot Schmidt⁶, Saskia Middeldorp⁷, Alexander T Cohen⁸, Jan Beyer-Westendorf⁹, Patrick Yue¹, Andrew Demchuk¹⁰, Mark Crowther³. ¹Portola Pharmaceuticals, Inc, South San Francisco, CA, USA. ²Seton Dell Medical School Stroke Institute, Austin, TX, USA. ³Population Health Research Institute, McMaster University, Hamilton, ON, Canada. ⁴Harvard Medical School, Boston, MA, USA. ⁵University of Leuven, Leuven Belgium. ⁶Centre Hospitalier Universitaire de Clermont-Ferrand, Clermont-Ferrand France. ⁷Academic Medical Center, Amsterdam Netherlands. ⁸Guy's and St. Thomas' Hospitals, King's College London, London United Kingdom. ⁹University Hospital Carl Gustav Carus Dresden, Dresden Germany. ¹⁰University of Calgary, Calgary, AB, Canada

Clinical Outcomes Following Administration of 4F-PCC for Management of Bleeding or Need for Emergent Procedure on a Xa Inhibitor - Good Enough, or Do We Need Other Agents?

Maura K. Wychowski, Christina I. Ruscio, Ronald L. Sham, Peter A. Kouides. Rochester General Hospital, Rochester, NY, USA

Effectiveness of antithrombotic therapy-related transitions of care with a focus on interfacility handoff communication

Chelsea Rodriguez^{1, 2}, Gabriel Garcia^{1, 2}, Gregory Hadlock¹, Lisa Koselke¹, Allison Burnett^{1, 2}. ¹University of New Mexico Hosptial, Albuquerque, NM, USA. ²University of New Mexico College of Pharmacy, Albuquerque, NM, USA

Assessment of the Knowledge about Venous Thromboembolism (VTE) on Pregnant Women Attending Kigali Referral Hospitals.

Christine ASHIMWE. Rwanda Clot Awareness Network, Kigali, Rwanda

Venous Thromboemobism Risk, Prophylaxis and Outcome in Admitted Patients to the Medical Wards of Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia

Tamrat Assefa¹, Feruza Ahmed¹. ¹Addis Ababa University, Addis Ababa, Ethiopia. ²Addis Ababa University, Addis Ababa, Ethiopia

Evaluation of Clinical Effectiveness and Safety of Direct Oral Anticoagulants: QAtar Registry on Direct oral anticoagulants (QARD-registry)

Abdul Moqeeth Mohammed¹, Abdelnasser Elzouki¹, Ahmed Sobhy Mahfouz¹, Hazem Elewa¹, Eman El-Hamoud¹, Osama Abdel-Samad¹, Sumaya Mehdar Al Saadi¹, Ezeldin Hamza Habab Soaly¹, Rasha Zakaria Enany¹, Muna A Qawi Al Bakri¹, Naseer Masoodi¹. ¹Hamad Medical Corporation, Doha, Qatar. ²Hamad Medical Corporation, Doha, Qatar. ³Hamad Medical Corporation, Doha, Qatar. ⁴Hamad Medical Corporation, Doha, Qatar. ⁵Hamad Medical Corporation, Doha, Qatar. ⁶Hamad Medical Corporation, Doha, Qatar. ⁷Hamad Medical Corporation, Doha, Qatar. ⁸Hamad Medical Corporation, Doha, Qatar. ⁹Hamad Medical Corporation, Doha, Qatar. ¹⁰Hamad Medical Corporation, Doha, Qatar. ¹¹Hamad Medical Corporation, Doha, Qatar

Real-World Assessment of Off-Label Direct Oral Anticoagulant Dosing for Venous Thromboembolism

John A. Saunders, Whitney L. Gustafson, Sara R. Vazquez, Aubrey E. Jones, Daniel M. Witt. University of Utah, Salt Lake City, UT, USA

Assessing the accuracy of International Classification of Disease (ICD)10 codes for thromboembolic events

Kevin F. Lawrence¹, Christopher Joos², Stacy A. Johnson³, Aubrey E. Jones⁴, Daniel M. Witt⁵. ¹University of Utah College of Pharmacy, Department of Pharmacotherapy, Salt Lake City, UT, USA. ²University of Utah College of Pharmacy, Department of Pharmacotherapy, Salt Lake City, UT, USA. ³University of Utah School of Medicine, Department of Internal Medicine, Salt Lake City, UT, USA. ⁴University of Utah College of Pharmacy, Department of Pharmacotherapy, Salt Lake City, UT, USA. ⁵University of Utah College of Pharmacy, Department of Pharmacotherapy, Salt Lake City, UT, USA

Comparison of Safety and Efficacy of Enoxaparin Regimens for Treatment of Venous Thromboembolism in the Setting of Cancer

Katerina Bakhmut, Claresta Bergman, Vika Bursua, Jaclyn Ng. Jesse Brown VAMC, Chicago, IL, USA

The Burden of Hospital Readmissions for Venous Thromboembolism Among Acute Medically Ill Patients in the US

Steven Deitelzweig¹, Alpesh Amin², Iwona Bucior³, Jay Lin⁴, Melissa Lingohr-Smith⁴, Brandy Menges⁴. ¹Ochsner Clinic Foundation, Department of Hospital Medicine and The University of Queensland School of Medicine, Ochsner Clinical School, New Orleans, LA, USA. ²University of California, Irvine, School of Medicine, Irvine, CA, USA. ³Portola Pharmaceuticals, South San Francisco, CA, USA. ⁴Novosys Health, Green Brook, NJ, USA

A Targeted Change in Practice to Alleviate Emotional Harm Related to Venous Thromboembolism (VTE) at University of Utah Health Care

Aubrey E. Jones¹, Ryan Fleming², Michael Feehan³, Stacy Johnson⁴, Daniel M. Witt¹. ¹University of Utah College of Pharmacy Department of Pharmacotherapy, Salt Lake City, UT, USA. ²Thrombosis Clinic, University of Utah Health, Salt Lake City, UT, USA. ³Kantar LLC, San Francisco, CA, USA. ⁴University of Utah School of Medicine, Department of Internal Medicine, Salt Lake City, UT, USA

Retrospective review of catheter directed thrombolysis for treatment of pulmonary embolism

Anne Rose¹, Josh DeGrave², Matthew Williams², Emily Zimmerman¹. ¹UW Health, Madison, WI, USA. ²UW School of Pharmacy, Madison, WI, USA